iPS细胞研究的新进展及应用

doi:10.3724/SP.J.1005.2010.01205

遗传 ›› 2010, Vol. 32 ›› Issue (12): 1205-1214.doi: 10.3724/SP.J.1005.2010.01205

iPS细胞研究的新进展及应用

秦彤, 苗向阳

中国农业科学院北京畜牧兽医研究所, 北京100193

收稿日期:2010-03-05 修回日期:2010-04-09 出版日期:2010-12-20 发布日期:2010-12-20
通讯作者: 苗向阳 E-mail:mxy32@sohu.com
基金资助:
国家高技术研究发展计划(863计划)项目(编号：2008AA10Z140), 转基因生物新品种培育科技重大专项(编号：2009ZXD8008-004B, 2009ZXD8008-003)和中国农业科学院创新基金项目(编号：2004-院-1)资助

Current progress and application prospects of induced pluripotent stem cells

QIN Tong, MIAO Xiang-Yang

Institute of Animal Scineces, Chinese Academy of Aricultural Sciences, Beijing 100193, China

Received:2010-03-05 Revised:2010-04-09 Online:2010-12-20 Published:2010-12-20
Contact: MIAO Xiang-Yang E-mail:mxy32@sohu.com

摘要/Abstract

摘要： 通过导入特定的转录因子可将分化的体细胞重编程为诱导性多能干细胞(Induced pluripotent stem cells, iPS cells), 这项技术避免了干细胞研究领域的免疫排斥和伦理道德问题, 是生命科学领域的一次巨大革命。与胚胎干细胞(Embryonic stem cells, ES cells)一样, iPS 细胞能够自我更新并维持未分化状态, 在体内可分化为3 个胚层来源的所有细胞, 进而参与形成机体所有组织和器官。在体外, iPS 细胞可定向诱导分化出多种成熟细胞。因此, iPS 细胞在理论研究和临床应用等方面都极具应用价值。文章对iPS细胞诱导的最新研究进展、iPS细胞诱导的不同方法, 如何提高iPS细胞的制备效率和安全性, iPS细胞在基础研究以及临床研究等方面的应用进行了全面综述, 并探讨了iPS细胞研究领域面临的问题以及该技术在转基因动物研究中的发展前景。

关键词: 诱导性多能干细胞, 胚胎干细胞, 转录因子, 重编程, 分化

Abstract: Induced pluripotent stem (iPS) cells can be directly generated from somatic cells by transduction of a few defined transcription factors. This technique avoids immunological rejection and ethical difficulties, which is a great revolution in life sciences. Like embryonic stem (ES) cells, iPS cells have the ability to self-renew through mitotic cell division and thus remain in its undifferentiated state and the ability to differentiate into not only all derivatives of the three primary germ layers: ectoderm, endoderm, and mesoderm, but also many mature cells in vitro. Therefore, iPS cells are important for theoretic study and therapeutic application. Here, we discuss recent advances in generating induced pluripotent stem cells, different reprogramming methods, and clinical applications of iPS cells. Finally, current problems of iPS cells and its pros-pects in transgenic animals are also discussed. This article is a summary of current research advances in reprogramming cells into induced pluripotent stem cells.

Key words: induced pluripotent stem cells, embryonic stem cell, transcription factor, reprogramming, differentiation

秦彤，苗向阳. iPS细胞研究的新进展及应用[J]. 遗传, 2010, 32(12): 1205-1214.

QIN Tong, MIAO Xiang-Yang. Current progress and application prospects of induced pluripotent stem cells[J]. HEREDITAS, 2010, 32(12): 1205-1214.

参考文献

[1] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4): 663–676. [2] Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131(5): 861–872. [3] Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318(5858): 1917–1920. [4] Schenke-Layland K, Rhodes KE, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, MacLellan WR. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovas-cular and hematopoietic lineages. Stem Cells, 2008, 26(6): 1537–1546. [5] Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and sub-sequent excision of reprogramming factors. Nature, 2009, 458(7239): 771–775. [6] Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 2009, 458(7239): 766–770. [7] Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 2009, 136(5): 964–977. [8] Liu HS, Zhu FF, Yong J, Zhang PB, Hou PP, Li HG, Jiang W, Cai J, Liu M, Cui K, Qu XX, Xiang TT, Lu DY, Chi XC, Gao G, Ji WZ, Ding MX, Deng HK. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell, 2008, 3(6): 587–590. [9] Li WL, Wei W, Zhu SY, Zhu JL, Shi Y, Lin TX, Hao EG, Hayek A, Deng HK, Ding S. Generation of rat and human induced pluripotent stem cells by combining genetic re-programming and chemical inhibitors. Cell Stem Cell, 2009, 4(1): 16–19. [10] Wu Z, Chen JJ, Ren JT, Bao L, Liao J, Cui C, Rao LJ, Li H, Gu YJ, Dai HM, Zhu H, Teng XK, Cheng L, Xiao L. Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol, 2009, 1(1): 46–54. [11] Esteban MA, Xu JY, Yang JY, Peng MX, Qin DJ, Li W, Jiang ZX, Chen JK, Deng K, Zhong M, Cai JL, Lai LX, Pei DQ. Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem, 2009, 284(26): 17634–17640. [12] Li CL, Yu HY, Ma Y, Shi GL, Jiang J, Gu JJ, Yang Y, Jin SB, Wei Z, Jiang H, Li JS, Jin Y. Germline-competent mouse-induced pluripotent stem cell lines generated on human fibroblasts without exogenous leukemia inhibitory factor. PLoS One, 2009, 4(8): e6724. [13] Li CL, Zhou JM, Shi GL, Ma Y, Yang Y, Gu JJ, Yu HY, Jin SB, Wei Z, Chen F, Jin Y. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet, 2009, 18(22): 4340–4349. [14] Wang YX, Jiang YH, Liu S, Sun XF, Gao SR. Generation of induced pluripotent stem cells from human β-thalassemia fi-broblast cells. Cell Res, 2009, 19(9): 1120–1123. [15] Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng FY, Zhou Q. iPS cells produce viable mice through tetraploid complementation. Nature, 2009, 461(7260): 86–90. [16] Zhang DH, Jiang W, Liu M, Sui X, Yin XL, Chen S, Shi Y, Deng HK. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insu-lin-producing cells. Cell Res, 2009, 19(4): 429–438. [17] Song ZH, Cai J, Liu YX, Zhao DX, Yong J, Duo SG, Song XJ, Guo YS, Zhao Y, Qin H, Yin

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

iPS细胞研究的新进展及应用

Current progress and application prospects of induced pluripotent stem cells

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	吴玲玲, 张小玉, 李晓, 靳建军, 杨公社, 史新娥. miR-196b-5p促进成肌细胞增殖分化[J]. 遗传, 2023, 45(5): 435-446.
[2]	田智琛, 尹晓娟. 诱导多能干细胞在儿童疾病的应用研究进展[J]. 遗传, 2023, 45(1): 42-51.
[3]	孙凤宇, 许强华. 血液发生相关microRNAs研究进展[J]. 遗传, 2022, 44(9): 756-771.
[4]	慕蓉蓉, 牛晴晴, 孙玉强, 梅俊, 苗蒙. 陆地棉MYB类转录因子基因GhTT2克隆及功能初步分析[J]. 遗传, 2022, 44(8): 720-728.
[5]	赵欢, 周斌. 胰岛beta细胞再生研究进展[J]. 遗传, 2022, 44(5): 370-382.
[6]	崔浩亮, 史佩华, 高锦春, 张新博, 赵顺然, 陶晨雨. 细胞重编程过程中核小体定位改变研究进展[J]. 遗传, 2022, 44(3): 208-215.
[7]	余志鑫, 李鹏宇, 李凯, 缪时英, 王琳芳, 宋伟. 精原干细胞微环境研究进展[J]. 遗传, 2022, 44(12): 1103-1116.
[8]	吕孟冈, 刘艾嘉, 李庆伟, 苏鹏. RHR转录因子家族起源、功能以及进化机制的研究进展[J]. 遗传, 2021, 43(3): 215-225.
[9]	邱晓芬, 汤冬娥, 虞海燕, 廖秋燕, 胡芷洋, 周俊, 赵鑫, 何慧燕, 梁灼健, 许承明, 杨明, 戴勇. 基于单细胞ATAC测序技术对18-三体综合征染色质开放性区域转录因子的分析[J]. 遗传, 2021, 43(1): 74-83.
[10]	妥晓梅, 朱东丽, 陈晓峰, 荣誉, 郭燕, 杨铁林. 骨质疏松易感SNP rs4325274通过增强子远程调控SOX6基因的功能机制研究[J]. 遗传, 2020, 42(9): 889-897.
[11]	邹礼平, 潘铖, 王梦馨, 崔林, 韩宝瑜. 激素调控植物成花机理研究进展[J]. 遗传, 2020, 42(8): 739-751.
[12]	吴杰, 全建平, 叶勇, 吴珍芳, 杨杰, 杨明, 郑恩琴. 染色质转座酶可及性测序研究进展[J]. 遗传, 2020, 42(4): 333-346.
[13]	杜坤, 毛初阳, 任安勇, 吴雪梅, 李庆玲, 陈婷婷, 陈仕毅, 赖松家. 家兔前体脂肪细胞分化不同时期基因表达谱分析[J]. 遗传, 2020, 42(3): 309-320.
[14]	王涛涛, 杨勇, 魏唯, 林辰涛, 马留银. 互花米草NAC转录因子家族的鉴定与表达分析[J]. 遗传, 2020, 42(2): 194-211.
[15]	陈万银, 颜一丹, 栾晓瑾, 王敏, 方杰. CG8005基因在果蝇睾丸生殖细胞中的功能分析[J]. 遗传, 2020, 42(11): 1122-1132.